Cargando…

Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience

OBJECTIVE: To summarize the multi-specialty strategy and initial guidelines of a Case Review Committee in triaging oncologic surgery procedures in a large Comprehensive Cancer Center and to outline current steps moving forward after the initial wave. SUMMARY OF BACKGROUND DATA: The impetus for strat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzeng, Ching-Wei D., Teshome, Mediget, Katz, Matthew H. G., Weinberg, Jeffrey S., Lai, Stephen Y., Antonoff, Mara B., Bird, Justin E., Shafer, Aaron, Davis, John W., Adelman, David M., Moon, Bryan, Reece, Gregory, Prabhu, Sujit S., DeSnyder, Sarah M., Skibber, John M., Mehran, Reza, Schmeler, Kathleen, Roland, Christina L., Tran Cao, Hop S., Aloia, Thomas A., Caudle, Abigail S., Swisher, Stephen G., Vauthey, Jean-Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott, Williams, and Wilkins 2020
Materias:	Covid Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373457/ https://www.ncbi.nlm.nih.gov/pubmed/32675511 http://dx.doi.org/10.1097/SLA.0000000000004092

Ejemplares similares

M.D. Anderson, Oncología /
Publicado: (2000)

Neoadjuvant treatment: the MD Anderson experience
por: Hortobagyi, GN
Publicado: (2005)

Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses
por: Wheler, Jennifer, et al.
Publicado: (2013)

Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization
por: Tran Cao, Hop, et al.
Publicado: (2020)

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
por: Mendoza, Tito, et al.
Publicado: (2020)

M.D. Anderson Cancer Center, oncología quirúrgica /
Publicado: (2005)

Obituary Notice of Thomas Anderson, M.D., F.L.S.
Publicado: (1870)

Effectiveness and Safety of Magseed Localization for Excision of Breast Lesions: A Prospective, Phase IV Trial
por: Singh, Puneet, et al.
Publicado: (2020)

45. Outcomes of Targeted Muscle Reinnervation and Regenerative Peripheral Nerve Interface in Oncologic Amputees: The MD Anderson Cancer Center Experience
por: Hassan, Abbas M., et al.
Publicado: (2023)

Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience
por: El Hussein, Siba, et al.
Publicado: (2020)

Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience
por: Conter, Henry J., et al.
Publicado: (2014)

Mario A. Luna, M.D. The University of Texas M.D. Anderson Cancer Center (January 21, 1935 to November 9, 2008)
por: El-Naggar, Adel K., et al.
Publicado: (2009)

Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience
por: Wang, Zhijie, et al.
Publicado: (2016)

LPTO-09. INTRATHECAL TOPOTECAN FOR LEPTOMENINGEAL METASTASIS IN SOLID TUMORS: THE MD ANDERSON EXPERIENCE
por: Sinicrope, Kaylyn D, et al.
Publicado: (2019)

Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience
por: Hahn, Andrew W., et al.
Publicado: (2023)

Introduction of Targeted Muscle Reinnervation (TMR) and Regenerative Peripheral Nerve Interfaces (RPNIs) for Chronic Pain Control and Prosthetic Function at MD Anderson Cancer Center: Review of 61 Cases and Outcomes
por: Roubaud, Margaret, et al.
Publicado: (2022)

Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
por: Vo, Henry Hiep, et al.
Publicado: (2022)

Evolution in Surgical Management of Breast Cancer-related Lymphedema: The MD Anderson Cancer Center Experience
por: Chang, Edward I., et al.
Publicado: (2020)

DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes
por: Kuerer, Henry M., et al.
Publicado: (2017)

Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach
por: Tzeng, Ching-Wei D., et al.
Publicado: (2020)

Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
por: Wang, Yinghong, et al.
Publicado: (2018)

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience
por: Tarek, Nidale, et al.
Publicado: (2020)

The Pioneer of Women Practitioners: Elizabeth Garrett Anderson, M.D. Paris, L.S.A.
Publicado: (1917)

A longitudinal study of the Swedish MD Anderson Dysphagia Inventory in patients with oral cancer
por: Tuomi, Lisa, et al.
Publicado: (2020)

ETMR-04. EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES: THE MD ANDERSON CANCER CENTER EXPERIENCE
por: Gupta, Sumit, et al.
Publicado: (2020)

Psychometric Properties of MD Anderson Symptoms Inventory for Acute Myeloid Leukemia Patients in Thailand
por: Rattanathammethee, Thanawat, et al.
Publicado: (2022)

The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades
por: Jabbour, Elias, et al.
Publicado: (2023)

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience
por: Nardo, Mirella, et al.
Publicado: (2023)

Evolution of Medical Modeling and 3D Printing in Microvascular Midface Reconstruction: Literature Review and Experience at MD Anderson Cancer Center
por: Shuck, John W., et al.
Publicado: (2023)

Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience
por: Richard-Carpentier, Guillaume, et al.
Publicado: (2021)

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience
por: Gregory, Timothy A, et al.
Publicado: (2023)

Making Cancer History: Disease and Discovery at the University of Texas M.D. Anderson Cancer Center
por: Hyland, Callen
Publicado: (2010)

Validity and Reliability of the Korean Version of the MD Anderson Dysphagia Inventory for Head and Neck Cancer Patients
por: Kwon, Chan-Hyuk, et al.
Publicado: (2013)

Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project
por: Edwards, Beatrice J., et al.
Publicado: (2017)

Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era
por: Gutierrez, Antonio, et al.
Publicado: (2020)

Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting
por: Kamal, Mona, et al.
Publicado: (2022)

Reply to a Case of Instrumental Delivery: Reported by W. Anderson, M.D., Leroy, Ill.
por: Travers, E. K.
Publicado: (1868)

Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID)
por: Williams, Loretta A., et al.
Publicado: (2023)

Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center
por: Vo, Henry Hiep, et al.
Publicado: (2022)

Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience
por: Majd, Nazanin K, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5vu3psbuof62as3unsp1jervk6